Christopher J. Jones

12.2k total citations
271 papers, 9.4k citations indexed

About

Christopher J. Jones is a scholar working on Organic Chemistry, Oncology and Molecular Biology. According to data from OpenAlex, Christopher J. Jones has authored 271 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Organic Chemistry, 75 papers in Oncology and 54 papers in Molecular Biology. Recurrent topics in Christopher J. Jones's work include Organometallic Complex Synthesis and Catalysis (55 papers), Metal complexes synthesis and properties (54 papers) and Magnetism in coordination complexes (39 papers). Christopher J. Jones is often cited by papers focused on Organometallic Complex Synthesis and Catalysis (55 papers), Metal complexes synthesis and properties (54 papers) and Magnetism in coordination complexes (39 papers). Christopher J. Jones collaborates with scholars based in United Kingdom, United States and Japan. Christopher J. Jones's co-authors include Richard D. Wood, Jon A. McCleverty, Kim H. Parker, Jonathan Goodfellow, Robert M. Macnab, David Wynford‐Thomas, D G Gibson, David Kipling, Liliana Raposo and Malcolm Lewis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of the American Chemical Society.

In The Last Decade

Christopher J. Jones

267 papers receiving 9.0k citations

Peers

Countries citing papers authored by Christopher J. Jones

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Jones more than expected).

Fields of papers citing papers by Christopher J. Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Jones. The network helps show where Christopher J. Jones may publish in the future.

Co-authorship network of co-authors of Christopher J. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Jones. A scholar is included among the top collaborators of Christopher J. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Jones. Christopher J. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy of HS-10382 (TERN-701) in tumor xenograft models, a new investigational allosteric ABL1 kinase inhibitor as a potential treatment for CML 2023 ·Journal of Pharmacology and Experimental Therapeutics ·Yuanfeng Zhou, Benjamin M. Parsons, Danni Sun, (unknown), Guoliang Chen, Mingjie Luo, Christopher J. Jones, (unknown), Xiaolei Wang, Yundong Sun, (unknown), Huifeng Niu	1
2	CML-593 The Novel BCR::ABL1 Allosteric Inhibitor HS-10382/TERN-701 is Potent Against Mutations Resistant to Active Site Tyrosine Kinase Inhibitors (TKIs) and Acts Synergistically With TKIs in BCR::ABL1+ Cancer Cell Lines 2023 ·Clinical Lymphoma Myeloma & Leukemia ·Benjamin M. Parsons, Christopher J. Jones, Danni Sun, (unknown), (unknown), Xiaolei Wang, Yundong Sun, Yuanfeng Zhou, (unknown)	0
3	Tumor-environment biomimetics delay peritoneal metastasis formation by deceiving and redirecting disseminated cancer cells 2015 ·Biomaterials ·Elly De Vlieghere, (unknown), Laurine Verset, (unknown), Christopher J. Jones, Bram De Craene, Geert Berx, Benedicte Descamps, Christian Vanhove, Jean‐Paul Remon, Wim Ceelen, Pieter Demetter, Marc Bracke, Bruno G. De Geest, Olivier De Wever	30
4	Glycosaminoglycans: Oligosaccharide Analysis by Liquid Chromatography, Capillary Electrophoresis, and Specific Labeling 2011 ·Methods in molecular biology ·(unknown), Christopher J. Jones, Szabolcs Béni, Cynthia K. Larive	10
5	Low temperature synthesis of ZnS and CdZnS shells on CdSe quantum dots 2010 ·Nanotechnology ·Huiguang Zhu, Arjun Prakash, Denise Benoit, Christopher J. Jones, Vicki L. Colvin	33
6	The extent of inaccurate aneroid sphygmomanometers in a hospital setting 2010 ·Wiener Medizinische Wochenschrift ·D. A. Cozanitis, Christopher J. Jones	2
7	Metyrapone Improves Endothelial Dysfunction in Patients With Treated Depression 2006 ·Journal of the American College of Cardiology ·A Broadley, Ania Korszun, Eltigani Abdelaal, Valentina Moskvina, John Deanfield, Christopher J. Jones, Michael Frenneaux	56
8	Investigation of the Signaling Pathways Involved in the Proliferative Life Span Barriers in Werner Syndrome Fibroblasts 2004 ·Annals of the New York Academy of Sciences ·Terence Davis, Richard Faragher, Christopher J. Jones, David Kipling	8
9	Replicative senescence in sheep fibroblasts is a p53 dependent process 2004 ·Experimental Gerontology ·Terence Davis, Julia W. Skinner, Richard Faragher, Christopher J. Jones, David Kipling	26
10	Telomere erosion triggers growth arrest but not cell death in human cancer cells retaining wild-type p53: implications for antitelomerase therapy 2004 ·Oncogene ·Ana Preto, Sim K. Singhrao, Michele F. Haughton, David Kipling, David Wynford‐Thomas, Christopher J. Jones	15
11	Abnormal metabolic fate of nitric oxide in Type I diabetes mellitus 2002 ·Diabetologia ·Alexandra Milsom, Christopher J. Jones, Jonathan Goodfellow, Michael Frenneaux, John R. Peters, Philip E. James	61
12	Clinical implications of telomerase detection 2001 ·Histopathology ·P.N. Matthews, Christopher J. Jones	19
13	Telomerase activity and telomere length in thyroid neoplasia: biological and clinical implications 2001 ·The Journal of Pathology ·P.N. Matthews, Christopher J. Jones, Julia W. Skinner, Michele F. Haughton, Cathérine De Micco, David Wynford‐Thomas	42
14	Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia 2000 ·Journal of the American College of Cardiology ·Jonathan Goodfellow, Michael Bellamy, Mark Ramsey, Christopher J. Jones, Malcolm Lewis	300
15	Real-time measurement of pulse wave velocity from arterial pressure waveforms 1995 ·Medical & Biological Engineering & Computing ·M W Ramsey, William R. Stewart, Christopher J. Jones	19
16	Mutation and expression of theXPA gene in revertants and hybrids of a xeroderma pigmentosum cell line 1994 ·Somatic Cell and Molecular Genetics ·James E. Cleaver, (unknown), Christopher J. Jones, Richard D. Wood, Deneb Karentz	11
17	The repair of large DNA adducts in mammalian cells 1992 ·Mutation Research/DNA Repair ·Raymond Waters, Christopher J. Jones, Elizabeth A. Martin, Aimin Yang, Nigel J. Jones	10
18	Hyperinsulinaemia and microvascular angina ("syndrome X") 1991 ·The Lancet ·Christopher J. Jones, S.J. Hutchison, A.H. Henderson, John Dean, John R. Peters	87
19	The syntheses and electrochemistry of bimetallic complexes containing molybdenum mononitrosyl redox centres linked by saturated-α,ω-diamido bridging ligands 1990 ·Polyhedron ·(unknown), Christopher J. Jones, Jon A. McCleverty	2
20	Effects of atropine and glycopyrrolate on neuromuscular transmission in the rat phrenic nerve-diaphragm preparation 1988 ·General Pharmacology The Vascular System ·(unknown), (unknown), E. McAteer, (unknown), Christopher J. Jones	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact